HOME > TRENDS
TRENDS
-
Edoxaban Approved in US with Restriction on Use; Impact on Daiichi Sankyo’s Midterm Business Plan Remains Unclear
January 30, 2015
-
Pneumococcal Vaccine Market Expanding with Inclusion in Publicly-Funded Vaccination Programs
January 16, 2015
-
Drug Makers Continue Trial and Error Efforts to Improve Lecture Meetings
January 9, 2015
-
ARBs at a Turning Point: Inroads by Generics to Lead to Gradual Decline in Sales
December 26, 2014
-
Pharmacist Society Criticizes Inappropriate Phrases in Materials Used by Sales Reps, Questions Use of Misleading Terms
December 19, 2014
-
Sales of Biosimilar EPO, G-CSF Growing as Awareness Increases
December 12, 2014
-
Industry Insiders, Healthcare Providers Call for Greater Focus on PMS by MRs, Criticize Excessive Focus on Product Promotion
December 5, 2014
-
Chugai’s Alecensa Off to a Good Start with Sales of 200 Million Yen in 1st Month
November 28, 2014
-
Bayer Sets Target of 30% Growth in Group Sales in Japan within 4 Years; Success to Depend Largely on 2 Core Products
November 21, 2014
-
Sales of Most Long-Listed Drugs Fall Short of Forecasts in Apr.-Sept.; Over 70% See Downward Revisions in Full-year Forecasts
November 11, 2014
-
Chugai Led in Research Grants Payment in FY2013; Grants Fell Among Major Drug Makers
November 5, 2014
-
Will Blopress AG Face Price War After Other Generics Debut in December?
November 5, 2014
-
Topical Combination Psoriasis Treatment Dovobet Debuts; Expected to Improve Patient QOL, Medication Adherence
October 31, 2014
-
Changes in Business Environment Spur Drug Makers to Reform Their Marketing Systems, Adopt Area Marketing Systems
October 22, 2014
-
LEP Agents Contributing to Expansion of Oral Contraceptives Market, Growing Use of Low-Dose Pill
October 10, 2014
-
Facing Unprecedented Patent Cliff for Abilify, Otsuka Holdings Sets Forth Plan to Achieve Recovery in 2018
September 24, 2014
-
Number of Females MRs Breaks 9,000 Mark with 1 in 3 in Their 20s, but Number in Management Positions Remains Low
September 19, 2014
-
With Entry of SGLT-2 Inhibitors, Competition Heating Up Again in Oral Anti-Diabetes Drug Market
September 12, 2014
-
Molecular-Targeted Treatments for Refractory Thyroid Cancer Debut, Giving Patients Hope
September 5, 2014
-
Competition Likely to Heat Up in RA Biologics Market Although Growth Continues
August 29, 2014
ページ
With a tumultuous year heading towards a close, let us share the 10 most-read stories on PHARMA JAPAN in 2020. With 2020 being a biennial drug price revision year, our global readers apparently had their eyes riveted on which products…
The Ministry of Health, Labor and Welfare (MHLW) on November 27 added to the NHI price list Japan’s first biosimilars of Avastin (bevacizumab), Nesp (darbepoetin alfa), and Forteo (teriparatide). The NHI prices of first biosimilars are set at 70% of…
As we navigate the lingering effects of the global pandemic, one thing is unmistakably clear - change is here. We’ve changed, and so have our companies. The entire workplace has transformed, but it’s not always a change for the better.…